These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19195410)

  • 1. Differentially expressed parasite genes involved in host recognition and invasion of the triactinomyxon stage of Myxobolus cerebralis (Myxozoa).
    Eszterbauer E; Kallert DM; Grabner D; El-Matbouli M
    Parasitology; 2009 Apr; 136(4):367-77. PubMed ID: 19195410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of nuclear DNA concentration in cells of Myxobolus cerebralis and triactinomyxon spores, the causative agent of whirling disease.
    El-Matbouli M; Holstein TW; Hoffmann RW
    Parasitol Res; 1998 Sep; 84(9):694-9. PubMed ID: 9766896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive site preference of the fish parasite
    Eszterbauer E; Sipos D; Szakály Á; Herczeg D
    Acta Vet Hung; 2019 Jun; 67(2):212-223. PubMed ID: 31238735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Myxobolus cerebralis infections among genetic lineages of Tubifex tubifex at three locations in the Madison River, Montana.
    Lodh N; Stevens L; Kerans B
    J Parasitol; 2011 Jun; 97(3):531-4. PubMed ID: 21506853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of Tetracapsuloides bryosalmonae and Myxobolus cerebralis co-infections on pathology in rainbow trout.
    Kotob MH; Gorgoglione B; Kumar G; Abdelzaher M; Saleh M; El-Matbouli M
    Parasit Vectors; 2017 Sep; 10(1):442. PubMed ID: 28946913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of habitat alteration on the epizootiology of Myxobolus cerebralis, the causative agent of salmonid whirling disease.
    Granath WO
    J Parasitol; 2014 Apr; 100(2):157-65. PubMed ID: 24383542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of immune-regulatory genes, arginase-2 and inducible nitric oxide synthase (iNOS), in two rainbow trout (Oncorhynchus mykiss) strains following exposure to Myxobolus cerebralis.
    Severin VI; Soliman H; El-Matbouli M
    Parasitol Res; 2010 Jan; 106(2):325-34. PubMed ID: 19894064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myxozoans
    Saleh M; Hummel K; Schlosser S; Razzazi-Fazeli E; Bartholomew JL; Holzer A; Secombes CJ; El-Matbouli M
    Front Cell Infect Microbiol; 2024; 14():1369615. PubMed ID: 38803570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo exposure of susceptible and non-susceptible fish species to Myxobolus cerebralis actinospores reveals non-specific invasion behaviour.
    Kallert DM; Eszterbauer E; Grabner D; El-Matbouli M
    Dis Aquat Organ; 2009 Apr; 84(2):123-30. PubMed ID: 19476282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation of host immune genes in the kidney and cranium of the rainbow trout (Oncorhynchus mykiss) in response to Tetracapsuloides bryosalmonae and Myxobolus cerebralis co-infections.
    Kotob MH; Kumar G; Saleh M; Gorgoglione B; Abdelzaher M; El-Matbouli M
    Parasit Vectors; 2018 May; 11(1):326. PubMed ID: 29848363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of rainbow trout Oncorhynchus mykiss epidermal mucus and evaluation of semiochemical activity for polar filament discharge in Myxobolus cerebralis actinospores.
    Kallert DM; Ponader S; Adelt S; Kaese P; Geyer R; Haas W; El-Matbouli M
    J Fish Biol; 2010 Nov; 77(7):1579-98. PubMed ID: 21078020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of local and systemic immune responses in brown trout (Salmo trutta) following exposure to Myxobolus cerebralis.
    Saleh M; Friedl A; Srivastava M; Secombes CJ; El-Matbouli M
    Fish Shellfish Immunol; 2020 Nov; 106():844-851. PubMed ID: 32891791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nested polymerase chain reaction for the detection of genomic DNA of Myxobolus cerebralis in rainbow trout Oncorhynchus mykiss.
    Andree KB; MacConnell E; Hedrick RP
    Dis Aquat Organ; 1998 Oct; 34(2):145-54. PubMed ID: 9828408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of glycans in the developmental stages of Myxobolus cerebralis (Myxozoa), the causative agent of whirling disease.
    Kaltner H; Stippl M; Knaus M; El-Matbouli M
    J Fish Dis; 2007 Nov; 30(11):637-47. PubMed ID: 17958607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of carbohydrate-binding sites in developmental stages of Myxobolus cerebralis.
    Knaus M; El-Matbouli M
    Parasitol Res; 2005 Dec; 97(6):505-14. PubMed ID: 16211413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A RNAi-based therapeutic proof of concept targets salmonid whirling disease in vivo.
    Sarker S; Menanteau-Ledouble S; Kotob MH; El-Matbouli M
    PLoS One; 2017; 12(6):e0178687. PubMed ID: 28575083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whirling disease: host specificity and interaction between the actinosporean stage of Myxobolus cerebralis and rainbow trout Oncorhynchus mykiss.
    el-Matbouli M; Hoffmann RW; Schoel H; McDowell TS; Hedrick RP
    Dis Aquat Organ; 1999 Jan; 35(1):1-12. PubMed ID: 10073310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and screening of a cDNA library from the triactinomyxon spores of Myxobolus cerebralis, the causative agent of salmonid whirling diseases.
    el-Matbouli M; Soliman H
    Parasitology; 2006 Apr; 132(Pt 4):467-77. PubMed ID: 16388692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whirling disease revisited: pathogenesis, parasite biology and disease intervention.
    Sarker S; Kallert DM; Hedrick RP; El-Matbouli M
    Dis Aquat Organ; 2015 May; 114(2):155-75. PubMed ID: 25993890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Sampling and Detection Methods for Chinook Salmon and Steelhead Naturally Infected with Myxobolus cerebralis.
    Chiaramonte LV; Burbank D; Scott R; Trushenski JT
    J Aquat Anim Health; 2018 Mar; 30(1):57-64. PubMed ID: 29595883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.